Chugai Pharmaceutical Co.... (CHGCY)
OTC: CHGCY
· Real-Time Price · USD
21.28
0.49 (2.36%)
At close: Aug 15, 2025, 3:59 PM
Chugai Pharmaceutical Cash Flow Statement
Financials in JPY. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 111.86B | 74.4B | 91.21B | 120.03B | 112.7B | 112.28B | 161.71B | 106.13B | 108.37B | 199.66B | 155.09B | 133.22B | 108.54B | 73.52B |
Depreciation & Amortization | n/a | 400M | 1.6B | 300M | 400M | 500M | 600M | 500M | 300M | 300M | 2.1B | 400M | 1.2B | n/a |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 69.68B | 44.11B | 12.76B | -11.69B | 5.38B | 124.19B | -198.86B | -6.56B | 55.26B | -33.16B | -61.63B | -8.6B | -53.06B | 109.86B |
Other Non-Cash Items | -110.89B | -16.34B | 19B | -77.34B | 8.2B | -109.23B | 9.54B | -74.88B | 9.45B | -93.96B | 1.5B | -42.95B | 975M | -67.14B |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 69.68B | 44.11B | 12.76B | -11.69B | 5.38B | 124.19B | -198.86B | -6.56B | 55.26B | -33.16B | -61.63B | -8.6B | -53.06B | 40.17B |
Operating Cash Flow | 70.65B | 101.77B | 124.56B | 31.3B | 126.67B | 127.75B | -27B | 25.19B | 173.39B | 72.54B | 94.96B | 81.67B | 56.46B | 46.54B |
Capital Expenditures | -22.24B | -12.53B | -18.22B | -9.37B | -19.48B | -27.19B | -12.01B | -8.92B | -13.53B | -36.79B | -7.85B | -25.15B | -7.97B | -31.89B |
Cash Acquisitions | n/a | n/a | 17.36B | 53M | -318M | 1.7B | -83M | -24M | 1.16B | n/a | -21M | 2.43B | 1.5B | 2.94B |
Purchase of Investments | -290.16B | -190.05B | -125.8B | -136.45B | -117.07B | -166.66B | -125.01B | -163.75B | -110.2B | -120.04B | -94.34B | -85.04B | -82.83B | -110.06B |
Sales Maturities Of Investments | 170.61B | 169.48B | 131.87B | 147.31B | 125.88B | 141.9B | 115B | 125.15B | 80B | 122.77B | 85.03B | 85B | 60B | 95B |
Other Investing Acitivies | 1.15B | -19.87B | 3M | 450M | 1.44B | 14.88B | 85M | 94M | 28M | 73M | 16M | -2.41B | -397M | -2.89B |
Investing Cash Flow | -140.65B | -33.1B | 5.21B | 1.99B | -9.55B | -35.37B | -22.02B | -47.45B | -42.55B | -33.98B | -17.17B | -25.16B | -29.7B | -46.9B |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -2M | -3M | 3M | -1M | -1M | -1M | -1M | -1M | -2M | -1M | -1M | -1M | -2M | -4M |
Dividend Paid | -540M | -64.96B | -368M | -65.41B | -452M | -65.37B | -422M | -62.06B | -581M | -75.16B | -320M | -49.01B | -263M | -49.05B |
Other Financial Acitivies | -2.07B | -1.98B | -1.99B | -1.99B | -1.95B | -2.04B | -1.94B | -1.95B | -1.91B | -1.85B | -2.66B | -2.03B | -2B | -2.07B |
Financial Cash Flow | -2.6B | -66.87B | -2.22B | -67.38B | -2.37B | -67.28B | -2.35B | -63.98B | -2.44B | -76.87B | -2.98B | -51.04B | -2.26B | -51.12B |
Net Cash Flow | -69.1B | 4.19B | 127.33B | -33.67B | 117.33B | 25.52B | -51.87B | -86.27B | 129.84B | -37.28B | 75.23B | 5.39B | 25.08B | -50.28B |
Free Cash Flow | 48.41B | 89.24B | 106.35B | 21.93B | 107.19B | 100.56B | -39.01B | 16.27B | 159.86B | 35.75B | 87.11B | 56.52B | 48.49B | 14.65B |